Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacy and Pharmacology|April 21, 2021
Assessment of calciprotein particle formation by AUC of the absorbance change: effect of FYB-931, a novel bisphosphonate compoundKoichi Ishida, Naoki Ashizawa, Shota Morikane, et al.
Archives of Toxicology|January 23, 2014
Xanthine crystals induced by topiroxostat, a xanthine oxidoreductase inhibitor, in rats, cause transitional cell tumorsTakeo Shimo, Mitsuyoshi Moto, Naoki Ashizawa, et al.
ACS Medicinal Chemistry Letters|October 16, 2020
Discovery of Dotinurad (FYU-981), a New Phenol Derivative with Highly Potent Uric Acid Lowering ActivityJunichiro Uda, Seiichi Kobashi, Sachiho Miyata, et al.
Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine|August 30, 2014
Operator-bias-free comparison of quantitative perfusion maps acquired with pulsed-continuous arterial spin labeling and single-photon-emission computed tomographyTakashi Iwanaga, Masafumi Harada, Hitoshi Kubo, et al.
Asia Pacific Journal of Clinical Nutrition|November 2, 2006
Effects of dietary supplements on the Fischer ratio before and after pulmonary rehabilitationHirokazu Kubo, Noritsugu Honda, Fumio Tsuji, et al.
Toxicologic Pathology|April 2, 2009
FYX-051, a xanthine oxidoreductase inhibitor, induces nephropathy in rats, but not in monkeysTakeo Shimo, Naoki Ashizawa, Mitsuyoshi Moto, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 17, 2010
Annual change of respiratory functions in adult patients with asthma: the potential of antiasthma treatments for many years to repair irreversible changes of the airwayMasato Muraki, Yusaku Nisikawa, Eri Naito, et al.
Pageof 13